SCHEMBL7554839

SCHEMBL7554839

CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1OCCCO[N+](=O)[O-]

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1C Q13936 12/20 0.53
▸ CACNA1F O60840 10/20 0.50
▸ CACNA1D Q01668 10/20 0.50
▸ CACNA1S Q13698 10/20 0.50
▸ ADORA3 P0DMS8 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 2/20 0.47
▸ LMNA P02545 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ ABCC4 O15439 2/20 0.47
▸ ABCB11 O95342 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ ADORA2A P29274 2/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ OPRM1 P35372 2/20 0.47
▸ SCN1A P35498 2/20 0.47
▸ HTR2B P41595 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7402137 0.97 CACNA1C (0.53) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7443841 0.96 CYP2C9 (0.54) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7544621 0.95 CACNA1C (0.54) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7446056 0.94 CYP2C9 (0.54) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7540434 0.92 CACNA1C (0.52) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7445246 0.90 ADORA3 (0.60) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7393785 0.87 CYP1A2 (0.58) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7396706 0.87 CYP1A2 (0.58) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL7365819 0.87 CYP1A2 (0.58) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL9248478 0.85 ADORA3 (0.61) CACNA1CCACNA1FCACNA1DCACNA1SADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995013812-A1 USE OF SUBSTITUTED 1,4-DIHYDROPYRIDINE TO REDUCE INTRAOCULAR PRESSURE BYK NEDERLAND BV (NL) 1995-05-26 — — WO claimed
EP-0541634-A1 1,4-DIHYDROPYRIDINE DERIVATIVES CEDONA PHARMACEUTICALS B.V. (NL) 1993-05-19 — — EP disclosed
Send feedback